Agashivala N - Search Results

1

The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement.

Stegall MD, Troy Somerville K, Everly MJ, Mannon RB, Gaber AO, First MR, Agashivala N, Perez V, Newell KA, Morris RE, Sudan D, Romero K, Eremenco S, Mattera M, Spear N, Porter AC, O'Doherty I. Stegall MD, et al. Among authors: agashivala n. Am J Transplant. 2019 Mar;19(3):625-632. doi: 10.1111/ajt.15214. Epub 2019 Jan 23. Am J Transplant. 2019. PMID: 30549395 Free article.

2

Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map.

Khanani AM, Zarbin MA, Barakat MR, Albini TA, Kaiser PK, B G, Agashivala N, Yu JS, Wykoff CC, MacCumber MW. Khanani AM, et al. Among authors: agashivala n. JAMA Ophthalmol. 2022 Jan 1;140(1):20-28. doi: 10.1001/jamaophthalmol.2021.4585. JAMA Ophthalmol. 2022. PMID: 34817566 Free PMC article.

3

Brolucizumab vs aflibercept and ranibizumab for neovascular age-related macular degeneration: a cost-effectiveness analysis.

Yu JS, Carlton R, Agashivala N, Hassan T, Wykoff CC. Yu JS, et al. Among authors: agashivala n. J Manag Care Spec Pharm. 2021 Jun;27(6):743-752. doi: 10.18553/jmcp.2021.27.6.743. J Manag Care Spec Pharm. 2021. PMID: 34057392 Free PMC article.

4

Antivascular endothelial growth factor agents for wet age-related macular degeneration: an IRIS registry analysis.

MacCumber MW, Yu JS, Sagkriotis A, B G, Burugapalli B, Bi X, Agashivala N, Wykoff CC. MacCumber MW, et al. Among authors: agashivala n. Can J Ophthalmol. 2023 Jun;58(3):252-261. doi: 10.1016/j.jcjo.2021.10.008. Epub 2021 Dec 2. Can J Ophthalmol. 2023. PMID: 34863677

5

Anti-VEGF Treatment Patterns in Patients With Wet Age-Related Macular Degeneration in Clinical Practice.

Singh RP, Yu JS, B G, Agashivala N. Singh RP, et al. Among authors: agashivala n. Ophthalmic Surg Lasers Imaging Retina. 2021 May;52(5):263-272. doi: 10.3928/23258160-20210429-04. Epub 2021 May 1. Ophthalmic Surg Lasers Imaging Retina. 2021. PMID: 34044715

6

Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.

Agashivala N, Wu N, Abouzaid S, Wu Y, Kim E, Boulanger L, Brandes DW. Agashivala N, et al. BMC Neurol. 2013 Oct 4;13:138. doi: 10.1186/1471-2377-13-138. BMC Neurol. 2013. PMID: 24093542 Free PMC article.

7

Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study.

Bergvall N, Makin C, Lahoz R, Agashivala N, Pradhan A, Capkun G, Petrilla AA, Karkare SU, McGuiness CB, Korn JR. Bergvall N, et al. Among authors: agashivala n. PLoS One. 2014 Feb 6;9(2):e88472. doi: 10.1371/journal.pone.0088472. eCollection 2014. PLoS One. 2014. PMID: 24516663 Free PMC article.

8

Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.

Bergvall N, Petrilla AA, Karkare SU, Lahoz R, Agashivala N, Pradhan A, Capkun G, Makin C, McGuiness CB, Korn JR. Bergvall N, et al. Among authors: agashivala n. J Med Econ. 2014 Oct;17(10):696-707. doi: 10.3111/13696998.2014.940422. Epub 2014 Jul 23. J Med Econ. 2014. PMID: 25019581 Free article.

9

Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.

Bergvall N, Makin C, Lahoz R, Agashivala N, Pradhan A, Capkun G, Petrilla A, Karkare SU, Balderston McGuiness C, Korn JR. Bergvall N, et al. Among authors: agashivala n. Curr Med Res Opin. 2013 Dec;29(12):1647-56. doi: 10.1185/03007995.2013.847411. Epub 2013 Oct 1. Curr Med Res Opin. 2013. PMID: 24059944

10

Cost-effectiveness of early initiation of fingolimod versus delayed initiation after 1 year of intramuscular interferon beta-1a in patients with multiple sclerosis.

Agashivala N, Kim E. Agashivala N, et al. Clin Ther. 2012 Jul;34(7):1583-90. doi: 10.1016/j.clinthera.2012.06.012. Epub 2012 Jun 28. Clin Ther. 2012. PMID: 22749258 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters